QC
BHVN icon

Quadrature Capital’s Biohaven BHVN Stock Holding History

Quadrature Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,663
Closed -$595K – 1393
2025
Q4 		$595K Buy
52,663
+33,291
+172% +$412K 0.01% 655
2025
Q3 		$291K Sell
19,372
-24,591
-56% -$358K ﹤0.01% 682
2025
Q2 		$620K Buy
+43,963
New +$784K 0.01% 512

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's BHVN Position: Q1 2026 in Review

Quadrature Capital sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 52,663 shares — an estimated $595K sold.

Quadrature Capital first reported a position in BHVN in Q2 2025 and held it in 3 quarters. The position peaked at $620K in Q2 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Quadrature Capital reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 52,663 Biohaven shares in Q1 2026, an estimated $595K.
  • Quadrature Capital first reported a position in Biohaven in Q2 2025 and held it in 3 quarters.
  • Quadrature Capital's Biohaven position peaked at $620K in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.